Indian Journal of Medical and Paediatric Oncology

LinksSchließen

Referenz

Romond EH, Jeong JH, Rastogi P, Swain SM, Geyer Jr. CE, Ewer MS. et al.
Seven-year follow-up assessment of cardiac function in NSABP B-31, a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel (ACP) with ACP plus trastuzumab as adjuvant therapy for patients with node-positive, human epidermal growth factor receptor 2-positive breast cancer.

J Clin Oncol 2012;
30: 3792-9

Bibliographische Angaben herunterladen

Aufrufen in: